The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The Survivin saga goes in vivo
Open accessAbstract
Survivin is a bifunctional protein that suppresses apoptosis and regulates cell division (1). This protein has garnered great interest as a potential drug target because its expression is among the most tumor-specific of all human gene products (2). While fetal tissues contain abundant Survivin mRNA and protein, most normal adult tissues do not. In contrast, the vast majority of tumors express Survivin protein at high levels, suggesting that reactivation of SURVIVIN gene expression occurs commonly in cancers (3). The mechanisms by which Survivin regulates cell death and cell division are highly controversial. Indeed, even the premise that Survivin regulates apoptosis has been challenged, primarily on the grounds that Survivin homologues in yeast and Caenorhabditis elegans operate as regulators of cell division but not cell survival (reviewed in refs. 4, 5). Heretofore, the preponderance of evidence that mammalian Survivin suppresses apoptosis was based on overexpression of the protein in cultured cell lines. The absence of in vivo data on this point has now been remedied with a paper in this issue of the JCI by Altieri and colleagues (6). In an accompanying paper (7), the same investigators show how emerging knowledge about Survivin regulation might be use to develop a new gene therapy strategy for cancer. Seeking to model events in tumors, Grossman et al. (6) placed the Survivin cDNA under the control of the keratin 14 (K14) promoter and generated transgenic mice that produce Survivin constitutively in epidermal keratinocytes. The skin is an easily accessible tissue that displays the full gamut of events relevant to tumorigenesis, including cell proliferation, differentiation, and death. Betting persons might have placed their wagers on seeing a defect in cell division or differentiation in K14-Survivin mice, but such was not the case. Instead, the keratinocytes of these Survivin-overexpressing mice demonstrated resistance to apoptosis, thus providing the first evidence that Survivin can suppress cell death in vivo. Specifically, overexpression of Survivin significantly reduced the numbers of apoptotic cells generated in the epidermis following exposure to ultraviolet-B (UVB) radiation (sunburn). While these data do not go as far as to establish a role for Survivin in homeostatic programmed cell death, they do at least indicate that the overexpression of Survivin (which is seen in many tumors) can result in an antiapoptotic state in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
Cited by
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2067 · Cited by 823
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
Mita, A. C., Mita, M. M., Nawrocki, S. T., & Giles, F. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0746 · Cited by 765
Anoikis resistance and tumor metastasis
Simpson, C. D., Anyiwe, K., & Schimmer, A. D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.029 · Cited by 644
Metadata
- Authors
- Reed, J. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-10-01
- Volume
- 108
- Issue
- 7
- Pages
- 965-969
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1984545745
- Cited by
- 232
- References
- 1
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Survivin saga goes in vivo. https://app.cochat.ai/papers/10.1172/jci14123
- The paper
- Reed, J. C. (2001). The Survivin saga goes in vivo. Journal of Clinical Investigation. https://doi.org/10.1172/jci14123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.